| Literature DB >> 33476567 |
Fang Li1, Yuan-Yuan Li2, Ming-Jin Liu3, Li-Qun Fang4, Natalie E Dean3, Gary W K Wong5, Xiao-Bing Yang1, Ira Longini3, M Elizabeth Halloran6, Huai-Ji Wang1, Pu-Lin Liu1, Yan-Hui Pang1, Ya-Qiong Yan1, Su Liu1, Wei Xia2, Xiao-Xia Lu7, Qi Liu2, Yang Yang8, Shun-Qing Xu9.
Abstract
BACKGROUND: Wuhan was the first epicentre of COVID-19 in the world, accounting for 80% of cases in China during the first wave. We aimed to assess household transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and risk factors associated with infectivity and susceptibility to infection in Wuhan.Entities:
Mesh:
Year: 2021 PMID: 33476567 PMCID: PMC7833912 DOI: 10.1016/S1473-3099(20)30981-6
Source DB: PubMed Journal: Lancet Infect Dis ISSN: 1473-3099 Impact factor: 25.071
Demographic and clinical characteristics of cases and test-negative or untested contacts of SARS-CoV-2-infected households in Wuhan, China, from Dec 2, 2019, to April 18, 2020
| <0·0001 | ||||||
| Median (IQR) | 56 (43–66) | 57 (44–66) | 55 (39–66) | 43 (28–58) | .. | |
| <20 | 908 (2·3%) | 413 (1·4%) | 495 (4·8%) | 7744/46 102 (16·8%) | .. | |
| 20–59 | 22 642 (56·7%) | 16 892 (57·1%) | 5750 (55·5%) | 27 749/46 102 (60·2%) | .. | |
| ≥60 | 16 395 (41·0%) | 12 273 (41·5%) | 4122 (39·8%) | 10 609/46 102 (23·0%) | .. | |
| <0·0001 | ||||||
| Female | 20 760 (52·0%) | 15 417 (52·1%) | 5343 (51·5%) | 22 674 (48·0%) | .. | |
| Male | 19 185 (48·0%) | 14 161 (47·9%) | 5024 (48·5%) | 24 540 (52·0%) | .. | |
| <0·0001 | ||||||
| 2 | 16 519 (41·4%) | 13 115 (44·3%) | 3404 (32·8%) | 8857 (18·8%) | .. | |
| 3–4 | 17 366 (43·5%) | 12 550 (42·4%) | 4816 (46·5%) | 22 598 (47·9%) | .. | |
| 5–6 | 4989 (12·5%) | 3276 (11·1%) | 1713 (16·5%) | 11 864 (25·1%) | .. | |
| >6 | 1071 (2·7%) | 637 (2·2%) | 434 (4·2%) | 3895 (8·2%) | .. | |
| Asymptomatic | 1006 (2·5%) | 567 (1·9%) | 439 (4·2%) | NA | <0·0001 | |
| Mild | 20 326 (50·9%) | 14 928 (50·5%) | 5398 (52·1%) | NA | .. | |
| Moderate | 11 504 (28·8%) | 8416 (28·5%) | 3088 (29·8%) | NA | .. | |
| Severe | 6193 (15·5%) | 4895 (16·5%) | 1298 (12·5%) | NA | .. | |
| Critical | 916 (2·3%) | 772 (2·6%) | 144 (1·4%) | NA | .. | |
| <0·0001 | ||||||
| Clinical | 11 441 (28·6%) | 8844 (29·9%) | 2597 (25·1%) | NA | .. | |
| Laboratory confirmed | 28 504 (71·4%) | 20 734 (70·1%) | 7770 (74·9%) | NA | .. | |
| Epidemic phase (based on onset of primary case) | <0·0001 | |||||
| Before Jan 24 | 7599 (19·0%) | 7146 (24·2%) | 453 (4·4%) | 11 869 (25·1%) | .. | |
| Jan 24–Feb 10 | 25 073 (62·8%) | 18 595 (62·9%) | 6478 (62·5%) | 27 685 (58·6%) | .. | |
| After Feb 10 | 7273 (18·2%) | 3837 (13·0%) | 3436 (33·1%) | 7660 (16·2%) | .. | |
NA=not applicable. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
Including 8619 asymptomatic contacts who might have been tested but whose laboratory test records were missing; these individuals were treated as untested in all analyses. Age data were missing for 1112 test-negative or untested household contacts.
χ2 test comparing secondary cases to uninfected contacts.
Severity categories were measured at the time of clinical assessment or laboratory testing. Mild cases include 280 cases for whom severity was missing. A total of 2060 cases died.
χ2 test comparing proportion of asymptomatic infections between secondary and primary cases.
χ2 test comparing secondary with primary cases.
FigureSpatial distribution of all confirmed COVID-19 cases and the retrospective cohort of contact-traced households reported during Dec 2, 2019–April 18, 2020, at the community level in Wuhan, China
(A) Distribution of all clinically or laboratory confirmed COVID-19 cases in Wuhan. (B) Distribution of all contact-traced households included in this study. (C) The community-level infection attack rate (ie, the cumulative number of confirmed cases as a percentage of the total population) in each district in Wuhan. (D) The observed household secondary attack rate (ie, the proportion of secondary infections among household contacts) among households with a single primary case included in this study. In B and D, the community of each household was determined by the community of the primary case, or the case with the earliest symptom onset if there were coprimary cases. CD= Cai-Dian. DXH= Dong-Xi-Hu. HN= Han-Nan. HP= Huang-Pi. HS=Hong-Shan. HY=Han-Yang. JA=Jiang-An. JH=Jiang-Han. JX= Jiang-Xia. QK=Qiao-Kou. QS= Qing-Shan. WC=Wu-Chang. XZ= Xin-Zhou.
Estimates of observed secondary attack rates among households with a single primary case
| Overall | 24 985 | 52 822 | 8447 | 16·0% (15·7–16·3) | .. | |
| Household size | ||||||
| 2 | 11 504 | 12 050 | 3270 | 27·1% (26·3–27·9) | 1 (ref) | |
| 3–4 | 10 322 | 24 961 | 3647 | 14·6% (14·2–15·1) | 0·56 (0·53–0·59) | |
| 5–6 | 2669 | 12 076 | 1231 | 10·2% (9·7–10·8) | 0·42 (0·39–0·46) | |
| >6 | 490 | 3735 | 299 | 8·0% (7·2–8·9) | 0·39 (0·34–0·46) | |
| Epidemic phase (based on onset of primary case) | ||||||
| Before Jan 24 | 6462 | 13 968 | 2674 | 19·1% (18·5–19·8) | 1·14 (1·07–1·21) | |
| Jan 24–Feb 10 | 15 152 | 31 127 | 5453 | 17·5% (17·1–18·0) | 1 (ref) | |
| After Feb 10 | 3371 | 7727 | 320 | 4·1% (3·7–4·6) | 0·25 (0·22–0·29) | |
| Age of contacts, years† | ||||||
| ≤1 | NA | 264 | 16 | 6·1% (3·5–9·7) | 0·32 (0·21–0·50) | |
| 2–5 | NA | 2018 | 55 | 2·7% (2·1–3·5) | 0·15 (0·12–0·19) | |
| 6–12 | NA | 2693 | 125 | 4·6% (3·9–5·5) | 0·23 (0·19–0·27) | |
| 13–19 | NA | 2263 | 141 | 6·2% (5·3–7·3) | 0·27 (0·23–0·32) | |
| 20–39 | NA | 13 639 | 1627 | 11·9% (11·4–12·5) | 0·48 (0·45–0·51) | |
| 40–59 | NA | 16 369 | 2828 | 17·3% (16·7–17·9) | 0·65 (0·61–0·69) | |
| 60–79 | NA | 11 783 | 2985 | 25·3% (24·5–26·1) | 1 (ref) | |
| ≥80 | NA | 1389 | 337 | 24·3% (22·0–26·6) | 1·03 (0·90–1·17) | |
| Sex of contacts | ||||||
| Female | NA | 25 682 | 4357 | 17·0% (16·5–17·4) | 1·11 (1·05–1·18) | |
| Male | NA | 27 140 | 4090 | 15·1% (14·7–15·5) | 1 (ref) | |
| Age of primary case, years | ||||||
| <20 | 327 | 793 | 46 | 5·8% (4·3–7·7) | 0·66 (0·48–0·90) | |
| 20–39 | 4373 | 10 476 | 1350 | 12·9% (12·3–13·5) | 0·97 (0·90–1·05) | |
| 40–59 | 9908 | 20 596 | 3114 | 15·1% (14·6–15·6) | 0·98 (0·92–1·04) | |
| 60–79 | 9248 | 18 539 | 3489 | 18·8% (18·3–19·4) | 1 (ref) | |
| ≥80 | 1129 | 2418 | 448 | 18·5% (17·0–20·1) | 0·96 (0·84–1·09) | |
| Sex of primary case | ||||||
| Female | 13 093 | 27 358 | 4259 | 15·6% (15·1–16·0) | 0·96 (0·91–1·02) | |
| Male | 11 892 | 25 464 | 4188 | 16·5% (16·0–16·9) | 1 (ref) | |
| Clinical severity of primary case | ||||||
| Asymptomatic | 524 | 1367 | 27 | 2·0% (1·3–2·9) | 0·34 (0·21–0·54) | |
| Mild or moderate | 19 556 | 41 030 | 6495 | 15·8% (15·5–16·2) | 1 (ref) | |
| Severe or critical | 4905 | 10 425 | 1925 | 18·5% (17·7–19·2) | 1·01 (0·94–1·08) | |
| Ascertainment of primary case | ||||||
| Clinical | 7599 | 15 215 | 2028 | 13·3% (12·8–13·9) | 0·72 (0·67–0·76) | |
| RT-PCR | 17 386 | 37 607 | 6419 | 17·1% (16·7–17·5) | 1 (ref) | |
Untested contacts were treated as uninfected in the calculations. Secondary attack rates are not based on the transmission model. Odds ratios are calculated from a multivariable generalised estimating equation model. NA=not applicable.
Age was missing for 1027 contacts in 744 single-primary-case households; these households were excluded from the estimation of observed secondary attack rates by age group and from the multivariate generalised estimating equation model.
Model-based estimates of secondary attack rates and odds ratios reflecting covariate effects on susceptibility and infectivity
| Maximum infectious period: 13 days | Maximum infectious period: 22 days | Maximum infectious period: 13 days | Maximum infectious period: 22 days | ||
|---|---|---|---|---|---|
| Overall | 10·4% (10·1–10·7) | 15·6% (15·2–16·0) | 12·3% (11·9–12·6) | 17·1% (16·7–17·5) | |
| Household size ( | |||||
| 3–4 | 0·60 (0·57–0·63) | 0·59 (0·56–0·62) | 0·59 (0·56–0·62) | 0·58 (0·55–0·61) | |
| 5–6 | 0·41 (0·38–0·43) | 0·40 (0·37–0·42) | 0·39 (0·37–0·42) | 0·39 (0·36–0·41) | |
| >6 | 0·32 (0·29–0·36) | 0·31 (0·28–0·35) | 0·31 (0·28–0·35) | 0·30 (0·27–0·34) | |
| Epidemic phase ( | |||||
| Before Jan 24 | 0·74 (0·69–0·79) | 0·72 (0·68–0·77) | 0·79 (0·74–0·84) | 0·77 (0·73–0·82) | |
| After Feb 10 | 0·86 (0·77–0·96) | 0·86 (0·77–0·95) | 0·63 (0·56–0·70) | 0·62 (0·56–0·69) | |
| Age group, years ( | |||||
| 0–1 | 0·34 (0·23–0·51) | 0·34 (0·23–0·51) | 0·34 (0·23–0·51) | 0·34 (0·23–0·51) | |
| 2–5 | 0·16 (0·13–0·19) | 0·16 (0·13–0·20) | 0·16 (0·13–0·19) | 0·16 (0·13–0·19) | |
| 6–12 | 0·22 (0·19–0·26) | 0·22 (0·19–0·26) | 0·22 (0·19–0·26) | 0·22 (0·19–0·26) | |
| 13–19 | 0·27 (0·23–0·31) | 0·27 (0·23–0·31) | 0·27 (0·23–0·31) | 0·27 (0·23–0·31) | |
| 20–39 | 0·50 (0·48–0·53) | 0·51 (0·48–0·54) | 0·50 (0·48–0·53) | 0·50 (0·48–0·53) | |
| 40–59 | 0·69 (0·65–0·72) | 0·69 (0·66–0·72) | 0·68 (0·65–0·72) | 0·69 (0·65–0·72) | |
| Female sex ( | 1·11 (1·06–1·16) | 1·11 (1·07–1·16) | 1·11 (1·06–1·16) | 1·11 (1·06–1·16) | |
| Age group, years ( | |||||
| <20 | 1·65 (1·32–2·05) | 1·58 (1·28–1·95) | 1·41 (1·13–1·77) | 1·38 (1·11–1·72) | |
| 20–39 | 1·12 (1·02–1·22) | 1·10 (1·02–1·20) | 1·08 (0·99–1·17) | 1·07 (0·99–1·16) | |
| 40–59 | 1·02 (0·95–1·09) | 1·02 (0·95–1·09) | 1·02 (0·95–1·08) | 1·02 (0·96–1·09) | |
| Female sex ( | 0·97 (0·91–1·04) | 0·98 (0·92–1·04) | 0·97 (0·91–1·03) | 0·97 (0·91–1·03) | |
| Disease severity: severe or critical ( | 0·91 (0·84–0·98) | 0·92 (0·85–0·98) | 0·94 (0·88–1·01) | 0·94 (0·88–1·00) | |
| Diagnosis: clinical ( | 0·75 (0·70–0·80) | 0·75 (0·70–0·80) | 0·73 (0·69–0·78) | 0·74 (0·69–0·78) | |
| Asymptomatic infection ( | |||||
| Up to Feb 1 | 0·88 (0·36–2·14) | 0·42 (0·17–1·04) | 0·61 (0·28–1·33) | 0·29 (0·13–0·65) | |
| From Feb 2 | 0·53 (0·38–0·76) | 0·21 (0·14–0·31) | 0·39 (0·27–0·56) | 0·16 (0·11–0·24) | |
| Before symptom onset ( | 0·76 (0·68–0·85) | 1·42 (1·30–1·55) | 1·46 (1·31–1·63) | 2·92 (2·67–3·19) | |
Data are secondary attack rate (95% CI) or odds ratio (95% CI). Overall secondary attack rates, regardless of characteristics of the infector, infectee, or household, were estimated with a separate model with fewer covariates than the model used to estimate odds ratios (appendix p 30), as some covariates will change the interpretation of the secondary attack rate. Estimates of baseline daily transmission probabilities within households and from an external source, as well as estimates of daily transmission probabilities between different age groups within households, are shown in the appendix (pp 32–33).
Primary analysis.
Estimates of effective household reproductive numbers for primary cases and secondary cases in different epidemic stages in 2020
| Maximum infectious period: 13 days | Maximum infectious period: 22 days | Maximum infectious period: 13 days | Maximum infectious period: 22 days | |
|---|---|---|---|---|
| Before Jan 24 | 0·19 (0·18–0·20) | 0·25 (0·24–0·26) | 0·24 (0·23–0·25) | 0·29 (0·28–0·30) |
| Jan 24–Feb 10 | 0·21 (0·20–0·22) | 0·25 (0·24–0·26) | 0·25 (0·24–0·26) | 0·28 (0·27–0·28) |
| After Feb 10 | 0·12 (0·11–0·13) | 0·12 (0·10–0·13) | 0·10 (0·092–0·12) | 0·10 (0·089–0·11) |
| Before Jan 24 | 0·14 (0·13–0·14) | 0·17 (0·16–0·18) | 0·17 (0·16–0·18) | 0·20 (0·19–0·21) |
| Jan 24–Feb 10 | 0·15 (0·14–0·15) | 0·17 (0·16–0·18) | 0·18 (0·17–0·18) | 0·19 (0·19–0·20) |
| After Feb 10 | 0·064 (0·058–0·071) | 0·063 (0·057–0·070) | 0·056 (0·050–0·062) | 0·055 (0·049–0·061) |
Data in parentheses are 95% CIs. Epidemic phases are defined by intervention policy (lockdown from Jan 23 to April 7, 2020, and tightened community management since Feb 11; panel).
Primary analysis.